The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Tech 5: Bitcoin Hits All-time High, Tech Stocks...

November 9, 2024

5 Top Weekly TSXV Stocks: BCM Resources Takes...

November 14, 2023

Massan Resource Drilling Confirms High Grade Continuity

September 30, 2025

Copper Prices Surge on US-China Deal Optimism, Tight...

October 29, 2025

Apple, MP Materials Ink US$500 Million Deal to...

July 17, 2025

Apollo Silver Announces Upsize of Private Placement Offering

October 4, 2025

Coeur Mining to Buy SilverCrest Metals for US$1.7...

October 5, 2024

JZR Gold Enters into Loan Agreement

February 12, 2025

John Feneck: Gold Landscape Never Better, Plus 9...

March 13, 2025

Crypto Market Update: Q1 2024 in Review

April 20, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,596)
    • Investing (5,287)
    • Politics (6,961)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved